Compile Data Set for Download or QSAR
maximum 50k data
Found 162 with Last Name = 'jarvis' and Initial = 'a'
TargetPoly [ADP-ribose] polymerase tankyrase-1 [1068-1325](Homo sapiens (Human))
Institute of Cancer Research

US Patent
LigandPNGBDBM192902(US9193689, IQ-034)
Affinity DataIC50:  12nMAssay Description:Tankyrase activity was assayed using a 96-well format HT Universal Chemiluminescent PARP Assay Kit (Trevigen, Inc, cat. no. 4676-096-K) according to ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPoly [ADP-ribose] polymerase tankyrase-1 [1068-1325](Homo sapiens (Human))
Institute of Cancer Research

US Patent
LigandPNGBDBM192909(US9193689, IQ-222)
Affinity DataIC50:  16nMAssay Description:Tankyrase activity was assayed using a 96-well format HT Universal Chemiluminescent PARP Assay Kit (Trevigen, Inc, cat. no. 4676-096-K) according to ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPoly [ADP-ribose] polymerase tankyrase-1 [1068-1325](Homo sapiens (Human))
Institute of Cancer Research

US Patent
LigandPNGBDBM192904(US9193689, IQ-130)
Affinity DataIC50:  16nMAssay Description:Tankyrase activity was assayed using a 96-well format HT Universal Chemiluminescent PARP Assay Kit (Trevigen, Inc, cat. no. 4676-096-K) according to ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPoly [ADP-ribose] polymerase tankyrase-1 [1068-1325](Homo sapiens (Human))
Institute of Cancer Research

US Patent
LigandPNGBDBM192905(US9193689, REF-5)
Affinity DataIC50:  17nMAssay Description:Tankyrase activity was assayed using a 96-well format HT Universal Chemiluminescent PARP Assay Kit (Trevigen, Inc, cat. no. 4676-096-K) according to ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPoly [ADP-ribose] polymerase tankyrase-1 [1068-1325](Homo sapiens (Human))
Institute of Cancer Research

US Patent
LigandPNGBDBM192895(US9193689, IQ-025)
Affinity DataIC50:  17nMAssay Description:Tankyrase activity was assayed using a 96-well format HT Universal Chemiluminescent PARP Assay Kit (Trevigen, Inc, cat. no. 4676-096-K) according to ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPoly [ADP-ribose] polymerase tankyrase-1 [1068-1325](Homo sapiens (Human))
Institute of Cancer Research

US Patent
LigandPNGBDBM192903(US9193689, REF-4)
Affinity DataIC50:  18nMAssay Description:Tankyrase activity was assayed using a 96-well format HT Universal Chemiluminescent PARP Assay Kit (Trevigen, Inc, cat. no. 4676-096-K) according to ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPoly [ADP-ribose] polymerase tankyrase-1 [1068-1325](Homo sapiens (Human))
Institute of Cancer Research

US Patent
LigandPNGBDBM192899(US9193689, IQ-003)
Affinity DataIC50:  21nMAssay Description:Tankyrase activity was assayed using a 96-well format HT Universal Chemiluminescent PARP Assay Kit (Trevigen, Inc, cat. no. 4676-096-K) according to ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPoly [ADP-ribose] polymerase tankyrase-1 [1068-1325](Homo sapiens (Human))
Institute of Cancer Research

US Patent
LigandPNGBDBM192901(US9193689, REF-3)
Affinity DataIC50:  24nMAssay Description:Tankyrase activity was assayed using a 96-well format HT Universal Chemiluminescent PARP Assay Kit (Trevigen, Inc, cat. no. 4676-096-K) according to ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPoly [ADP-ribose] polymerase tankyrase-1 [1068-1325](Homo sapiens (Human))
Institute of Cancer Research

US Patent
LigandPNGBDBM192907(US9193689, REF-6)
Affinity DataIC50:  24nMAssay Description:Tankyrase activity was assayed using a 96-well format HT Universal Chemiluminescent PARP Assay Kit (Trevigen, Inc, cat. no. 4676-096-K) according to ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPoly [ADP-ribose] polymerase tankyrase-1 [1068-1325](Homo sapiens (Human))
Institute of Cancer Research

US Patent
LigandPNGBDBM192908(US9193689, IQ-220)
Affinity DataIC50:  26nMAssay Description:Tankyrase activity was assayed using a 96-well format HT Universal Chemiluminescent PARP Assay Kit (Trevigen, Inc, cat. no. 4676-096-K) according to ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPoly [ADP-ribose] polymerase tankyrase-1 [1068-1325](Homo sapiens (Human))
Institute of Cancer Research

US Patent
LigandPNGBDBM192897(US9193689, IQ-080)
Affinity DataIC50:  29nMAssay Description:Tankyrase activity was assayed using a 96-well format HT Universal Chemiluminescent PARP Assay Kit (Trevigen, Inc, cat. no. 4676-096-K) according to ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPoly [ADP-ribose] polymerase tankyrase-1 [1068-1325](Homo sapiens (Human))
Institute of Cancer Research

US Patent
LigandPNGBDBM192896(US9193689, REF-1)
Affinity DataIC50:  33nMAssay Description:Tankyrase activity was assayed using a 96-well format HT Universal Chemiluminescent PARP Assay Kit (Trevigen, Inc, cat. no. 4676-096-K) according to ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPoly [ADP-ribose] polymerase tankyrase-1 [1068-1325](Homo sapiens (Human))
Institute of Cancer Research

US Patent
LigandPNGBDBM192900(US9193689, IQ-002)
Affinity DataIC50:  39nMAssay Description:Tankyrase activity was assayed using a 96-well format HT Universal Chemiluminescent PARP Assay Kit (Trevigen, Inc, cat. no. 4676-096-K) according to ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPoly [ADP-ribose] polymerase tankyrase-1 [1068-1325](Homo sapiens (Human))
Institute of Cancer Research

US Patent
LigandPNGBDBM192912(US9193689, REF-8)
Affinity DataIC50:  39nMAssay Description:Tankyrase activity was assayed using a 96-well format HT Universal Chemiluminescent PARP Assay Kit (Trevigen, Inc, cat. no. 4676-096-K) according to ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPoly [ADP-ribose] polymerase tankyrase-1 [1068-1325](Homo sapiens (Human))
Institute of Cancer Research

US Patent
LigandPNGBDBM192910(US9193689, REF-7)
Affinity DataIC50:  42nMAssay Description:Tankyrase activity was assayed using a 96-well format HT Universal Chemiluminescent PARP Assay Kit (Trevigen, Inc, cat. no. 4676-096-K) according to ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPoly [ADP-ribose] polymerase tankyrase-1 [1068-1325](Homo sapiens (Human))
Institute of Cancer Research

US Patent
LigandPNGBDBM192898(US9193689, REF-2)
Affinity DataIC50:  48nMAssay Description:Tankyrase activity was assayed using a 96-well format HT Universal Chemiluminescent PARP Assay Kit (Trevigen, Inc, cat. no. 4676-096-K) according to ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPoly [ADP-ribose] polymerase tankyrase-1 [1068-1325](Homo sapiens (Human))
Institute of Cancer Research

US Patent
LigandPNGBDBM192906(US9193689, IQ-157)
Affinity DataIC50:  51nMAssay Description:Tankyrase activity was assayed using a 96-well format HT Universal Chemiluminescent PARP Assay Kit (Trevigen, Inc, cat. no. 4676-096-K) according to ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPoly [ADP-ribose] polymerase tankyrase-1 [1068-1325](Homo sapiens (Human))
Institute of Cancer Research

US Patent
LigandPNGBDBM192911(US9193689, IQ-223)
Affinity DataIC50:  76nMAssay Description:Tankyrase activity was assayed using a 96-well format HT Universal Chemiluminescent PARP Assay Kit (Trevigen, Inc, cat. no. 4676-096-K) according to ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase kinase 4(Homo sapiens (Human))
Imperial College Innovations

US Patent
LigandPNGBDBM628205(US11795169, Example 2)
Affinity DataIC50: <100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase kinase 4(Homo sapiens (Human))
Imperial College Innovations

US Patent
LigandPNGBDBM628211(US11795169, Example 7)
Affinity DataIC50: <100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase kinase 4(Homo sapiens (Human))
Imperial College Innovations

US Patent
LigandPNGBDBM628212(US11795169, Example 8)
Affinity DataIC50: <100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase kinase 4(Homo sapiens (Human))
Imperial College Innovations

US Patent
LigandPNGBDBM628213(US11795169, Example 9)
Affinity DataIC50: <100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase kinase 4(Homo sapiens (Human))
Imperial College Innovations

US Patent
LigandPNGBDBM628214(US11795169, Example 10)
Affinity DataIC50: <100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase kinase 4(Homo sapiens (Human))
Imperial College Innovations

US Patent
LigandPNGBDBM628215(US11795169, Example 11)
Affinity DataIC50: <100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase kinase 4(Homo sapiens (Human))
Imperial College Innovations

US Patent
LigandPNGBDBM628217(US11795169, Example 13)
Affinity DataIC50: <100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase kinase 4(Homo sapiens (Human))
Imperial College Innovations

US Patent
LigandPNGBDBM628218(US11795169, Example 14)
Affinity DataIC50: <100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase kinase 4(Homo sapiens (Human))
Imperial College Innovations

US Patent
LigandPNGBDBM628219(US11795169, Example 15)
Affinity DataIC50: <100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase kinase 4(Homo sapiens (Human))
Imperial College Innovations

US Patent
LigandPNGBDBM628221(US11795169, Example 16)
Affinity DataIC50: <100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase kinase 4(Homo sapiens (Human))
Imperial College Innovations

US Patent
LigandPNGBDBM628222(US11795169, Example 17)
Affinity DataIC50: <100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase kinase 4(Homo sapiens (Human))
Imperial College Innovations

US Patent
LigandPNGBDBM628224(US11795169, Example 18)
Affinity DataIC50: <100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase kinase 4(Homo sapiens (Human))
Imperial College Innovations

US Patent
LigandPNGBDBM628225(US11795169, Example 19)
Affinity DataIC50: <100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase kinase 4(Homo sapiens (Human))
Imperial College Innovations

US Patent
LigandPNGBDBM628229(US11795169, Example 23)
Affinity DataIC50: <100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase kinase 4(Homo sapiens (Human))
Imperial College Innovations

US Patent
LigandPNGBDBM628231(US11795169, Example 25)
Affinity DataIC50: <100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase kinase 4(Homo sapiens (Human))
Imperial College Innovations

US Patent
LigandPNGBDBM628232(US11795169, Example 26)
Affinity DataIC50: <100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase kinase 4(Homo sapiens (Human))
Imperial College Innovations

US Patent
LigandPNGBDBM628233(US11795169, Example 27)
Affinity DataIC50: <100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase kinase 4(Homo sapiens (Human))
Imperial College Innovations

US Patent
LigandPNGBDBM628234(US11795169, Example 28)
Affinity DataIC50: <100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase kinase 4(Homo sapiens (Human))
Imperial College Innovations

US Patent
LigandPNGBDBM628235(US11795169, Example 29)
Affinity DataIC50: <100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase kinase 4(Homo sapiens (Human))
Imperial College Innovations

US Patent
LigandPNGBDBM628239(US11795169, Example 33)
Affinity DataIC50: <100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase kinase 4(Homo sapiens (Human))
Imperial College Innovations

US Patent
LigandPNGBDBM628241(US11795169, Example 35)
Affinity DataIC50: <100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase kinase 4(Homo sapiens (Human))
Imperial College Innovations

US Patent
LigandPNGBDBM628242(US11795169, Example 36)
Affinity DataIC50: <100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase kinase 4(Homo sapiens (Human))
Imperial College Innovations

US Patent
LigandPNGBDBM628243(US11795169, Example 37)
Affinity DataIC50: <100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase kinase 4(Homo sapiens (Human))
Imperial College Innovations

US Patent
LigandPNGBDBM628244(US11795169, Example 38)
Affinity DataIC50: <100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase kinase 4(Homo sapiens (Human))
Imperial College Innovations

US Patent
LigandPNGBDBM628245(US11795169, Example 39)
Affinity DataIC50: <100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase kinase 4(Homo sapiens (Human))
Imperial College Innovations

US Patent
LigandPNGBDBM628246(US11795169, Example 40)
Affinity DataIC50: <100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase kinase 4(Homo sapiens (Human))
Imperial College Innovations

US Patent
LigandPNGBDBM628247(US11795169, Example 41)
Affinity DataIC50: <100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase kinase 4(Homo sapiens (Human))
Imperial College Innovations

US Patent
LigandPNGBDBM628248(US11795169, Example 42)
Affinity DataIC50: <100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase kinase 4(Homo sapiens (Human))
Imperial College Innovations

US Patent
LigandPNGBDBM628249(US11795169, Example 43)
Affinity DataIC50: <100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase kinase 4(Homo sapiens (Human))
Imperial College Innovations

US Patent
LigandPNGBDBM628251(US11795169, Example 45)
Affinity DataIC50: <100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase kinase 4(Homo sapiens (Human))
Imperial College Innovations

US Patent
LigandPNGBDBM628252(US11795169, Example 46)
Affinity DataIC50: <100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase kinase 4(Homo sapiens (Human))
Imperial College Innovations

US Patent
LigandPNGBDBM628254(US11795169, Example 48)
Affinity DataIC50: <100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 162 total ) | Next | Last >>
Jump to: